×
Olanzapine Plus Samidorphan (ALKS 3831) in Schizophrenia and Comorbid Alcohol Use Disorder: A Phase 2, Randomized Clinical Trial PDF
$ 40.00
Olanzapine Plus Samidorphan (ALKS 3831) in Schizophrenia and Comorbid Alcohol Use Disorder: A Phase 2, Randomized Clinical Trial PDF quantity
$ 40.00
×
Sluggish Cognitive Tempo as a Possible Predictor of Methylphenidate Response in Children With ADHD: A Randomized Controlled Trial PDF
$ 40.00
Sluggish Cognitive Tempo as a Possible Predictor of Methylphenidate Response in Children With ADHD: A Randomized Controlled Trial PDF quantity
$ 40.00
×
Safety, Tolerability, and Clinical Effect of Low-Dose Buprenorphine for Treatment-Resistant Depression in Midlife and Older Adults PDF
$ 40.00
Safety, Tolerability, and Clinical Effect of Low-Dose Buprenorphine for Treatment-Resistant Depression in Midlife and Older Adults PDF quantity
$ 40.00
×
Clinical Factors Associated With Treatment Resistance in Major Depressive Disorder: Results From a European Multicenter Study PDF
$ 40.00
Clinical Factors Associated With Treatment Resistance in Major Depressive Disorder: Results From a European Multicenter Study PDF quantity
$ 40.00
×
Impact of Comorbid Attention Deficit Disorder on the Direct Medical Costs of Treating Adults With Depression in Managed Care PDF
$ 40.00
Impact of Comorbid Attention Deficit Disorder on the Direct Medical Costs of Treating Adults With Depression in Managed Care PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart